In animals, curcumin supplementation was shown to reduce obesity and glucose intolerance, fibrosis, and intrahepatic accumulation of CD4+ cells in association with NAFLD (37). Here, CD4 is linked to metabolic dysfunction-associated steatotic liver disease.